Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT06440707

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06440707
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06440707. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-15 (actual); primary completion 2030-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
Acronym
TESSERACT 2
Condition
Acute Ischemic Stroke
Intervention (Device)
High-definition Cathodal Transcranial Direct Current Stimulation (HD C-tDCS)
Intervention (Device)
Sham tDCS
Lead sponsor
University of California, Los Angeles (class: other)
Collaborator
Johns Hopkins University (class: other)
Collaborator
Duke University (class: other)
Collaborator
Cedars-Sinai Medical Center (class: other)
Collaborator
University of California, San Francisco (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct06440707
Content hash
f737ca0d6de8fb4f591756475eb56ac6cd232a067f37a90b00c30cf0ef513528